Related Articles
Anthracycline‑induced cardiotoxicity in the chemotherapy treatment of breast cancer: Preventive strategies and treatment (Review)
Prolonged corrected QT dispersion
Pegylated liposomal doxorubicin: Pharmacologic and clinical evidence of potent antitumor activity with reduced anthracycline-induced cardiotoxicity (Review)
Serum B-type natriuretic peptide levels as a marker for anthracycline-induced cardiotoxicity
The mRNA expression of <em>Il6</em> and <em>Pdcd1</em> are predictive and protective factors for doxorubicin‑induced cardiotoxicity